HTL-023

N/A

Report date: 2022/11/10 18:02:55
NME

Base Information

Drug NameHTL-023
Drug Alias NameHTL-023HTL'023
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 2 receptor agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucagon-like peptide 2 receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseIntestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNxera Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseIntestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A